Retaglutide is a novel GLP-1 receptor agonist currently under study for the control of metabolic disorders. This drug works by mimicking the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone https://ronaldzunf949813.blogkoo.com/trelaglutide-exploring-a-new-treatment-for-chronic-diseases-58335060